Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR)

Historical Holders from Q2 2020 to Q3 2025

Symbol
PHAR on Nasdaq
Type / Class
Equity / Ordinary Shares / American Depositary Shares
Shares outstanding
705,983,417
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
58,257
Holdings value
$844,731
% of all portfolios
0%
Number of holders
7
Number of buys
4
Number of sells
-1
Average buys %
0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MORGAN STANLEY 1.2% $70,739,538 8,471,801 Morgan Stanley 31 Mar 2025

Institutional Holders of Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 58,257 $844,731 +$1,902 $14.5 7
2025 Q2 58,026 $620,298 +$75,322 $10.69 3
2025 Q1 51,003 $426,701 -$1,676 $8.37 3
2024 Q4 51,101 $514,333 +$64,544 $10.07 5
2024 Q3 44,747 $369,164 +$138,704 $8.25 4
2024 Q2 27,592 $230,393 +$58,701 $8.35 4
2024 Q1 20,562 $215,901 +$546 $10.5 3
2023 Q4 20,510 $234,429 -$263,673 $11.43 2
2023 Q3 25,930 $295,602 +$267,102 $11.4 3
2023 Q2 24,960 $290,784 -$11,894 $11.65 2
2023 Q1 25,841 $295,644 -$51,546 $13.5 3
2022 Q4 29,510 $325,137 +$49,840 $11.03 3
2022 Q3 24,984 $245,000 +$44,126 $9.78 3
2022 Q2 20,472 $180,000 -$1,433 $8.8 3
2022 Q1 20,586 $184,000 +$17,832 $8.88 4
2021 Q4 18,628 $166,000 -$77,219 $8.92 3
2021 Q3 26,355 $249,000 -$1,873,745 $9.46 4
2021 Q2 198,407 $2,237,000 +$413 $11.27 7
2021 Q1 192,149 $2,465,000 -$21,866,828 $12.83 3
2020 Q4 1,896,857 $2,963,000 +$2,963,000 $8.42 2
2020 Q2 16,500 $145,000 $8.79 1